活動性担癌患者における脳梗塞発症後の死亡関連因子に関する検討

【背景および目的】脳梗塞を発症した担癌患者の生存率に影響する因子として,複数の因子が報告されているが,深部静脈血栓症(DVT)については検討が不十分である.本研究では,活動性担癌患者の脳梗塞発症後の死亡に関連する因子について,DVT の影響を含め検討した.【方法】当院に入院した急性期脳梗塞患者のうち,癌を合併し,脳梗塞後の経過を 6 カ月間観察することのできた 94 例を対象とし,脳梗塞発症後の死亡イベントに対する各因子の関連性について,ロジスティック回帰分析にて多変量解析を行った.【結果】脳梗塞後の 6 カ月以内に死亡した症例は 40 例であり, D-dimer 高値,DVT ありが独立した...

Full description

Saved in:
Bibliographic Details
Published in脳卒中 Vol. 44; no. 3; pp. 252 - 258
Main Authors 山内, 淳司, 赤須, 友香利, 長谷川, 泰弘, 山野, 嘉久, 土橋, 瑶子, 今井, 健, 清水, 高弘, 秋山, 久尚
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本脳卒中学会 2022
日本脳卒中学会
Subjects
Online AccessGet full text
ISSN0912-0726
1883-1923
DOI10.3995/jstroke.10968

Cover

Abstract 【背景および目的】脳梗塞を発症した担癌患者の生存率に影響する因子として,複数の因子が報告されているが,深部静脈血栓症(DVT)については検討が不十分である.本研究では,活動性担癌患者の脳梗塞発症後の死亡に関連する因子について,DVT の影響を含め検討した.【方法】当院に入院した急性期脳梗塞患者のうち,癌を合併し,脳梗塞後の経過を 6 カ月間観察することのできた 94 例を対象とし,脳梗塞発症後の死亡イベントに対する各因子の関連性について,ロジスティック回帰分析にて多変量解析を行った.【結果】脳梗塞後の 6 カ月以内に死亡した症例は 40 例であり, D-dimer 高値,DVT ありが独立した死亡関連因子であることが示され,D-dimer≥4.1 mg/dl 群で死亡を多く認めた.【結論】D-dimer 高値あるいは DVT を合併した担癌脳梗塞患者は,死亡リスクが高い可能性が示唆された.
AbstractList 要旨: 【背景および目的】脳梗塞を発症した担癌患者の生存率に影響する因子として, 複数の因子が報告されているが, 深部静脈血栓症(DVT)については検討が不十分である. 本研究では, 活動性担癌患者の脳梗塞発症後の死亡に関連する因子について, DVTの影響を含め検討した. 【方法】当院に入院した急性期脳梗塞患者のうち, 癌を合併し, 脳梗塞後の経過を6カ月間観察することのできた94例を対象とし, 脳梗塞発症後の死亡イベントに対する各因子の関連性について, ロジスティック回帰分析にて多変量解析を行った. 【結果】脳梗塞後の6カ月以内に死亡した症例は40例であり, D-dimer高値, DVTありが独立した死亡関連因子であることが示され, D-dimer≧4.1mg/dl群で死亡を多く認めた. 【結論】D-dimer高値あるいはDVTを合併した担癌脳梗塞患者は, 死亡リスクが高い可能性が示唆された.
【背景および目的】脳梗塞を発症した担癌患者の生存率に影響する因子として,複数の因子が報告されているが,深部静脈血栓症(DVT)については検討が不十分である.本研究では,活動性担癌患者の脳梗塞発症後の死亡に関連する因子について,DVT の影響を含め検討した.【方法】当院に入院した急性期脳梗塞患者のうち,癌を合併し,脳梗塞後の経過を 6 カ月間観察することのできた 94 例を対象とし,脳梗塞発症後の死亡イベントに対する各因子の関連性について,ロジスティック回帰分析にて多変量解析を行った.【結果】脳梗塞後の 6 カ月以内に死亡した症例は 40 例であり, D-dimer 高値,DVT ありが独立した死亡関連因子であることが示され,D-dimer≥4.1 mg/dl 群で死亡を多く認めた.【結論】D-dimer 高値あるいは DVT を合併した担癌脳梗塞患者は,死亡リスクが高い可能性が示唆された.
Author 長谷川, 泰弘
今井, 健
清水, 高弘
土橋, 瑶子
赤須, 友香利
秋山, 久尚
山内, 淳司
山野, 嘉久
Author_xml – sequence: 1
  fullname: 山内, 淳司
  organization: 聖マリアンナ医科大学難病治療研究センター病因病態解析部門
– sequence: 1
  fullname: 赤須, 友香利
  organization: 聖マリアンナ医科大学脳神経内科
– sequence: 1
  fullname: 長谷川, 泰弘
  organization: 新百合ヶ丘総合病院脳神経内科
– sequence: 1
  fullname: 山野, 嘉久
  organization: 聖マリアンナ医科大学難病治療研究センター病因病態解析部門
– sequence: 1
  fullname: 土橋, 瑶子
  organization: 聖マリアンナ医科大学脳神経内科
– sequence: 1
  fullname: 今井, 健
  organization: 川崎市立多摩病院神経内科
– sequence: 1
  fullname: 清水, 高弘
  organization: 聖マリアンナ医科大学脳神経内科
– sequence: 1
  fullname: 秋山, 久尚
  organization: 聖マリアンナ医科大学脳神経内科
BookMark eNo9kEtLw0AUhQdRsD6W_ozovM0spfiCghvduBkmk6lNramkunDXiCJYEV1oKYpYFRREN7qy4J-JSeu_cGzFzTn3cjnnwjcGhsNqaACYQnCaCMFmyrWdqLppphEU3B0COeS6xEECk2GQgwJhB85iPgoma7XAg8ylgggucmA9e--kjYus_pg1Drutk2z_vlc_TOLnJD5O4vNkv9E7eMvummn7ptv66DaP0s-TJH7NXjpfH-3vy7vv-n16dZu-nNmIXZO4ZSPZw3Xv6XQCjBRVpWYm_3wcrC3Mr-aXnMLK4nJ-ruCUCSLc0X6RMp9pj3lCGe6jWYYFgkRzpn1ihEEaCqMYdYsQex6nXhEbwgk2SGnKFRkHi4PeLeMHWlWqYSUIjSxXd6PQ_pV-ifTZSAwxlhBSCok1O2LWF5dC5EIObVN-0GRhqg0jt6NgS0V7UkU7ga7YygFjSakkv9Jn_X_VJRXJsiI_sYaYvw
ContentType Journal Article
Copyright 2022 日本脳卒中学会
Copyright_xml – notice: 2022 日本脳卒中学会
CorporateAuthor 聖マリアンナ医科大学脳神経内科
聖マリアンナ医科大学難病治療研究センター病因病態解析部門
川崎市立多摩病院神経内科
新百合ヶ丘総合病院脳神経内科
CorporateAuthor_xml – name: 川崎市立多摩病院神経内科
– name: 聖マリアンナ医科大学脳神経内科
– name: 新百合ヶ丘総合病院脳神経内科
– name: 聖マリアンナ医科大学難病治療研究センター病因病態解析部門
DOI 10.3995/jstroke.10968
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1883-1923
EndPage 258
ExternalDocumentID dh3strok_2022_004403_002_0252_02584018060
article_jstroke_44_3_44_10968_article_char_ja
GroupedDBID 123
2WC
ALMA_UNASSIGNED_HOLDINGS
EIHBH
GROUPED_DOAJ
JSF
KQ8
MOJWN
RJT
ID FETCH-LOGICAL-j3136-cdf45d5cb5b9ae6d17529103c65cd3e9e1c09ea548f02bb64bf2e3632e1ac46a3
ISSN 0912-0726
IngestDate Thu Jul 10 16:14:23 EDT 2025
Wed Sep 03 06:30:11 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 3
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j3136-cdf45d5cb5b9ae6d17529103c65cd3e9e1c09ea548f02bb64bf2e3632e1ac46a3
OpenAccessLink http://dx.doi.org/10.3995/jstroke.10968
PageCount 7
ParticipantIDs medicalonline_journals_dh3strok_2022_004403_002_0252_02584018060
jstage_primary_article_jstroke_44_3_44_10968_article_char_ja
PublicationCentury 2000
PublicationDate 20220000
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – year: 2022
  text: 20220000
PublicationDecade 2020
PublicationTitle 脳卒中
PublicationTitleAlternate 脳卒中
PublicationYear 2022
Publisher 一般社団法人 日本脳卒中学会
日本脳卒中学会
Publisher_xml – name: 一般社団法人 日本脳卒中学会
– name: 日本脳卒中学会
References 10) Schwarzbach CJ, Schaefer A, Ebert A, et al.: Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology. Stroke 43: 3029–3034, 2012
27) Asakura H, Takahashi H, Uchiyama T, et al.: Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J 14: 42, 2016
28) Kawasugi K, Wada H, Hatada T, et al.: Prospective evaluation of hemostatic abnormalities in overt DIC due to various underlying diseases. Thromb Res 128: 186–190, 2011
29) Watanabe J, Otani S, Sakamoto T, et al.: Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer. Surg Today 46: 1258–1267, 2016
23) Dentali F, Pegoraro S, Barco S, et al.: Clinical course of isolated distal deep vein thrombosis in patients with active cancer: a multicenter cohort study. J Thromb Haemost 15: 1757–1763, 2017
11) Goldhaber SZ, Bounameaux H: Pulmonary embolism and deep vein thrombosis. Lancet 379: 1835–1846, 2012
16) Tripodi A: D-dimer testing in laboratory practice. Clin Chem 57: 1256–1262, 2011
25) Seok JM, Kim SG, Kim JW, et al.: Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol 68: 213–219, 2010
7) Powers WJ, Rabinstein AA, Ackerson T, et al.: 2018 Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49: e46–e110, 2018
2) Navi BB, Reiner AS, Kamel H, et al.: Association between incident cancer and subsequent stroke. Ann Neurol 77: 291–300, 2015
13) Forrest LM, McMillan DC, McArdle CS, et al.: Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89: 1028–1030, 2003
22) Yamashita Y, Shiomi H, Morimoto T, et al.: Asymptomatic lower extremity deep vein thrombosis - clinical characteristics, management strategies, and long-term outcomes. Circ J 81: 1936–1944, 2017
26) Fujinami J, Ohara T, Kitani-Morii F, et al.: Cancer-associated hypercoagulation increases the risk of early recurrent stroke in patients with active cancer. Cerebrovasc Dis 46: 46–51, 2018
19) Uno K, Homma S, Satoh T, et al.: Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer 96: 290–295, 2007
3) Varki A: Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood 110: 1723–1729, 2007
14) Chew HK, Wun T, Harvey D, et al.: Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 166: 458–464, 2006
4) Dammacco F, Vacca A, Procaccio P, et al.: Cancer-related coagulopathy (Trousseau’s syndrome): review of the literature and experience of a single center of internal medicine. Clin Exp Med 13: 85–97, 2013
6) Navi BB, Singer S, Merkler AE, et al.: Recurrent thromboembolic events after ischemic stroke in patients with cancer. Neurology 83: 26–33, 2014
15) McMillan DC: The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 39: 534–540, 2013
17) Kim K, Lee JH: Risk factors and biomarkers of ischemic stroke in cancer patients. J Stroke 16: 91–96, 2014
18) De Cicco M: The prothrombotic state in cancer: pathogenic mechanisms. Crit Rev Oncol Hematol 50: 187–196, 2004
20) Kuderer NM, Ortel TL, Francis CW: Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. J Clin Oncol 27: 4902–4911, 2009
5) Lee MJ, Chung JW, Ahn MJ, et al.: Hypercoagulability and mortality of patients with stroke and active cancer: The OASIS-CANCER study. J Stroke 19: 77–87, 2017
21) Nierodzik M, Karpatkin S: Hypercoagulability preceding cancer. Does hypercoagulability awaken dormant tumor cells in the host? J Thromb Haemost 3: 577–580, 2005
9) Lee MJ, Chung JW, Ahn MJ, et al.: Hypercoagulability snd mortality of patients with stroke and active cancer: The OASIS-CANCER Study. J Stroke 19: 77–87, 2017
24) Sørensen HT, Mellemkjaer L, Olsen JH, et al.: Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343: 1846–1850, 2000
12) Yoo J, Nam HS, Kim YD, et al.: Short-term outcome of ischemic stroke patients with systemic malignancy. Stroke 50: 507–511, 2019
1) Cestari DM, Weine DM, Panageas KS, et al.: Stroke in patients with cancer: incidence and etiology. Neurology 62: 2025–2030, 2004
8) Tsuchihashi Y, Shimizu T, Akiyama H, et al.: The risk factors for death within 6 months after ischemic stroke in patients with cancer. J Stroke Cerebrovasc Dis 29: 105365, 2020 doi: 10. 1016/j.jstrokecerebrovasdis.2020.105365
References_xml – reference: 9) Lee MJ, Chung JW, Ahn MJ, et al.: Hypercoagulability snd mortality of patients with stroke and active cancer: The OASIS-CANCER Study. J Stroke 19: 77–87, 2017
– reference: 22) Yamashita Y, Shiomi H, Morimoto T, et al.: Asymptomatic lower extremity deep vein thrombosis - clinical characteristics, management strategies, and long-term outcomes. Circ J 81: 1936–1944, 2017
– reference: 8) Tsuchihashi Y, Shimizu T, Akiyama H, et al.: The risk factors for death within 6 months after ischemic stroke in patients with cancer. J Stroke Cerebrovasc Dis 29: 105365, 2020 doi: 10. 1016/j.jstrokecerebrovasdis.2020.105365
– reference: 3) Varki A: Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood 110: 1723–1729, 2007
– reference: 20) Kuderer NM, Ortel TL, Francis CW: Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. J Clin Oncol 27: 4902–4911, 2009
– reference: 23) Dentali F, Pegoraro S, Barco S, et al.: Clinical course of isolated distal deep vein thrombosis in patients with active cancer: a multicenter cohort study. J Thromb Haemost 15: 1757–1763, 2017
– reference: 18) De Cicco M: The prothrombotic state in cancer: pathogenic mechanisms. Crit Rev Oncol Hematol 50: 187–196, 2004
– reference: 16) Tripodi A: D-dimer testing in laboratory practice. Clin Chem 57: 1256–1262, 2011
– reference: 29) Watanabe J, Otani S, Sakamoto T, et al.: Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer. Surg Today 46: 1258–1267, 2016
– reference: 17) Kim K, Lee JH: Risk factors and biomarkers of ischemic stroke in cancer patients. J Stroke 16: 91–96, 2014
– reference: 1) Cestari DM, Weine DM, Panageas KS, et al.: Stroke in patients with cancer: incidence and etiology. Neurology 62: 2025–2030, 2004
– reference: 5) Lee MJ, Chung JW, Ahn MJ, et al.: Hypercoagulability and mortality of patients with stroke and active cancer: The OASIS-CANCER study. J Stroke 19: 77–87, 2017
– reference: 21) Nierodzik M, Karpatkin S: Hypercoagulability preceding cancer. Does hypercoagulability awaken dormant tumor cells in the host? J Thromb Haemost 3: 577–580, 2005
– reference: 10) Schwarzbach CJ, Schaefer A, Ebert A, et al.: Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology. Stroke 43: 3029–3034, 2012
– reference: 14) Chew HK, Wun T, Harvey D, et al.: Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 166: 458–464, 2006
– reference: 11) Goldhaber SZ, Bounameaux H: Pulmonary embolism and deep vein thrombosis. Lancet 379: 1835–1846, 2012
– reference: 4) Dammacco F, Vacca A, Procaccio P, et al.: Cancer-related coagulopathy (Trousseau’s syndrome): review of the literature and experience of a single center of internal medicine. Clin Exp Med 13: 85–97, 2013
– reference: 2) Navi BB, Reiner AS, Kamel H, et al.: Association between incident cancer and subsequent stroke. Ann Neurol 77: 291–300, 2015
– reference: 28) Kawasugi K, Wada H, Hatada T, et al.: Prospective evaluation of hemostatic abnormalities in overt DIC due to various underlying diseases. Thromb Res 128: 186–190, 2011
– reference: 7) Powers WJ, Rabinstein AA, Ackerson T, et al.: 2018 Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49: e46–e110, 2018
– reference: 12) Yoo J, Nam HS, Kim YD, et al.: Short-term outcome of ischemic stroke patients with systemic malignancy. Stroke 50: 507–511, 2019
– reference: 25) Seok JM, Kim SG, Kim JW, et al.: Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol 68: 213–219, 2010
– reference: 13) Forrest LM, McMillan DC, McArdle CS, et al.: Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89: 1028–1030, 2003
– reference: 24) Sørensen HT, Mellemkjaer L, Olsen JH, et al.: Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343: 1846–1850, 2000
– reference: 26) Fujinami J, Ohara T, Kitani-Morii F, et al.: Cancer-associated hypercoagulation increases the risk of early recurrent stroke in patients with active cancer. Cerebrovasc Dis 46: 46–51, 2018
– reference: 15) McMillan DC: The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 39: 534–540, 2013
– reference: 6) Navi BB, Singer S, Merkler AE, et al.: Recurrent thromboembolic events after ischemic stroke in patients with cancer. Neurology 83: 26–33, 2014
– reference: 19) Uno K, Homma S, Satoh T, et al.: Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer 96: 290–295, 2007
– reference: 27) Asakura H, Takahashi H, Uchiyama T, et al.: Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J 14: 42, 2016
SSID ssib058493969
ssib002671006
ssj0065046
ssib002227608
ssib000940399
ssib059951213
ssib002670963
ssib029852171
ssib002484663
Score 2.2937293
Snippet 【背景および目的】脳梗塞を発症した担癌患者の生存率に影響する因子として,複数の因子が報告されているが,深部静脈血栓症(DVT)については検討が不十分である.本研...
要旨: 【背景および目的】脳梗塞を発症した担癌患者の生存率に影響する因子として, 複数の因子が報告されているが, 深部静脈血栓症(DVT)については検討が不十分である. 本研...
SourceID medicalonline
jstage
SourceType Publisher
StartPage 252
SubjectTerms cancer
D-dimer
deep venous thrombosis
ischemic stroke
Title 活動性担癌患者における脳梗塞発症後の死亡関連因子に関する検討
URI https://www.jstage.jst.go.jp/article/jstroke/44/3/44_10968/_article/-char/ja
http://mol.medicalonline.jp/library/journal/download?GoodsID=dh3strok/2022/004403/002&name=0252-0258j
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 脳卒中, 2022, Vol.44(3), pp.252-258
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1883-1923
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0065046
  issn: 0912-0726
  databaseCode: KQ8
  dateStart: 19790101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1883-1923
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0065046
  issn: 0912-0726
  databaseCode: DOA
  dateStart: 20220101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NaxQxFB9KBRFE_MT6RQ8GvIxmk_lIwIOZ7ZQi1FOF4mXYmZ1FKrbSbi-eusUi2CJ60FIUsa2gIPWipxb8Z9bdtv-F7yXZ3dlSxCoss5nk5eWX9zKT97LJW8e5nuZBJqtV4VJ4Q7owX9dc6efUraUhzC4MZrgaLuiP3wvG7nt3J_3JgcEbhV1L8_X0Zvb00HMl_6JVyAO94inZI2i2yxQyIA36hStoGK5_pWMSByTySBSR2CciItLHHEGJCnUiIgJyQiIlEWWdw4jiJBZIg0UcDEmiIpsQyiZkSScYckBiaIJjdcWIDLEtBTSx5RwpnQiJ0EVRrNsynGNda0Qj9JASKsaSSM0KEgiVYy0ZEUU15xEiaQFYl9gAkwVgkO8RWUaECkDGRTu7ABskAzyZBgCU3R3OGmwJP0gSoDxguGmRhp2Ko1ClRy9I5GObAArACmHoNZnQUFWgEfpYpmSvokTNAFfkQHVC38qRboscCzC3TKQ4BKFE6Yq406KE3kndIyjwiys3rOfh2x6DjFEYgKiMigL8oCIrcm4bx4Gj9RMpjQe0qfRYAvGq8h-EaVUGHcccAK-Ka7-4HydkNga5mfmE4C6a-8Wp0YTmtK8AXpznTNhhazIxE33_4GyMp6ZxNp6rz848yjFwmfkHpQMBzu3jk1i6xPMSjhdNn3RK8RBiMgWe0DEWgk1ZWDwxjoJH-xxrBlS06FiDnV0INMcwbGH_fYn29hswKcCs7TlKYKVLLoMuf4zSh7EQOzYfuDnmSGBHsCaaLwrgVl_3wc6Fex3O4-Rj80usiYhTMGonTjunrDc6rEzvzzgDU5WzzvFxu9_mnPOg_WOntfymvfC5vby0u7bSXtzcW1hqNr42Gy-ajdfNxeW9Z9_bG6ut9Q-7a9u7q89bP1eajW_trZ1f2-v7bzf2FzZb7z62tl5BFbhtNtagSvvT-70vL88790fjifKYa_-NxZ3iJR64WbXm-VU_S_1UVvKgCn4HA1-DZ4GfVXku81JGZV7xPVGjLE0DL62xnAec5aVK5gUVfsEZnJ6Zzi86w1TIvJpKT2Sh8CqSAiVNK0HmC5FnNGNDzm0jpeSJCbmTHGmMDDl3-mSb2Ff2XFJ9yDWDBB_HBDezUA5fkIQBjRfhYUDDgF76PwSXnRPYglmqveIM1mfn86vgvNTTa3rc_gZG1Qr4
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%B4%BB%E5%8B%95%E6%80%A7%E6%8B%85%E7%99%8C%E6%82%A3%E8%80%85%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E8%84%B3%E6%A2%97%E5%A1%9E%E7%99%BA%E7%97%87%E5%BE%8C%E3%81%AE%E6%AD%BB%E4%BA%A1%E9%96%A2%E9%80%A3%E5%9B%A0%E5%AD%90%E3%81%AB%E9%96%A2%E3%81%99%E3%82%8B%E6%A4%9C%E8%A8%8E&rft.jtitle=%E8%84%B3%E5%8D%92%E4%B8%AD&rft.au=%E5%B1%B1%E5%86%85%2C+%E6%B7%B3%E5%8F%B8&rft.au=%E8%B5%A4%E9%A0%88%2C+%E5%8F%8B%E9%A6%99%E5%88%A9&rft.au=%E9%95%B7%E8%B0%B7%E5%B7%9D%2C+%E6%B3%B0%E5%BC%98&rft.au=%E5%B1%B1%E9%87%8E%2C+%E5%98%89%E4%B9%85&rft.date=2022&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E8%84%B3%E5%8D%92%E4%B8%AD%E5%AD%A6%E4%BC%9A&rft.issn=0912-0726&rft.eissn=1883-1923&rft.volume=44&rft.issue=3&rft.spage=252&rft.epage=258&rft_id=info:doi/10.3995%2Fjstroke.10968&rft.externalDocID=article_jstroke_44_3_44_10968_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0912-0726&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0912-0726&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0912-0726&client=summon